Replies to post #2204 on Moleculin Biotech Inc (MBRX)

[BooDog]

Pretty much filled the gaps. Things are looking quite good for MBRX. Many bio's will see trials interrupted by COVID-19. Need to see Moleculin added t of potential benefits to helping the sick.

https://www.genengnews.com/virology/coronavirus/catching-up-to-coronavirus-top-60-treatments-in-development/?utm_medium=newsletter&utm_source=GEN+Press+Releases&utm_content=01&utm_campaign=GEN+Press+Releases_20200319&oly_enc_id=0784E2210356H1E